BIOMARIN PHARMACEUTICAL, INC.

Lobbying client · California · filed 2025 to 2025

Pharmaceutical company.

$60,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. 2 further filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the client's LDA id (67827), not by name.

Firms hired 1

LMH STRATEGIC SOLUTIONS $60,000 4 filings

Reported by year 1 year

2025 $60,000 4 filings

Issues lobbied 2

Medicare/Medicaid 4
Pharmacy 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Executive Office of the President (EOP) 2
Health & Human Services, Dept of (HHS) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 6 total

4T

LMH STRATEGIC SOLUTIONS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Apr 17, 2026

View → Q4

LMH STRATEGIC SOLUTIONS Amended

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 12, 2026

View → Q3

LMH STRATEGIC SOLUTIONS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 20, 2025

View → 2A

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2025 · posted Oct 6, 2025

View → Q2

LMH STRATEGIC SOLUTIONS Amended

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 21, 2025

View → RR

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.